Suita, Japan

Hitoshi Ichihashi


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hitoshi Ichihashi: Innovator in Quinolone Antibiotics

Introduction

Hitoshi Ichihashi is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release preparations of quinolone antibiotics. With a total of 3 patents to his name, Ichihashi's work has the potential to enhance the efficacy of antibiotic treatments.

Latest Patents

Ichihashi's latest patents focus on the formulation of orally administrable preparations that release quinolone antibiotics with a delay. The first patent, titled "Sustained-release preparations of quinolone antibiotics," describes a preparation that allows for a controlled release of the active compound. The second patent, "Method of preparing sustained-release preparations of quinolone antibiotics," outlines the process for creating these innovative formulations. Both patents aim to improve patient outcomes by optimizing the delivery of antibiotics.

Career Highlights

Hitoshi Ichihashi is currently associated with Bayer Schering Pharma AG, a leading global pharmaceutical company. His work at Bayer has allowed him to collaborate with other experts in the field and contribute to advancements in antibiotic therapies. His innovative approach to drug formulation has garnered attention within the pharmaceutical community.

Collaborations

Ichihashi has worked alongside notable colleagues, including Venkata-Rangarao Kanikanti and Roland Rupp. These collaborations have facilitated the exchange of ideas and expertise, further enhancing the development of effective pharmaceutical solutions.

Conclusion

Hitoshi Ichihashi's contributions to the field of quinolone antibiotics exemplify the importance of innovation in pharmaceuticals. His patents and ongoing work at Bayer Schering Pharma AG highlight his commitment to improving healthcare through advanced drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…